Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12615000409572
Ethics application status
Approved
Date submitted
4/11/2014
Date registered
30/04/2015
Date last updated
22/08/2018
Type of registration
Prospectively registered

Titles & IDs
Public title
Changes in the portal flow after pumping technique of liver to individuals attending osteopathic consultation for any disorder whose pathophysiology has been related to liver function
Scientific title
Changes in the portal flow after pumping technique of liver to individuals attending osteopathic consultation for any disorder whose pathophysiology has been related to liver function
Secondary ID [1] 285595 0
none
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Any disorder whose pathophysiology has been related to liver function. 293437 0
spinal pains condition 294768 0
headache condition 294769 0
Condition category
Condition code
Oral and Gastrointestinal 293708 293708 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The pumping technique: To such end, the subject place in a supine position with knees bent and the therapist standing on the left hand side of the patient, near the abdominal area. The left hand goes under the costal border to lift the costal chest. The right hand rests on the lower chest on the right side to compress the liver through the costal wall. The lower hand lifts the ribs while the upper hand exerts compression. The patient is asked to inhale deeply, and on exhaling the compression is performed with the hands, and during deep inspiration. This will be repeated for 10 respiratory cycles. Thus, through the anteroposterior contact on the liver, using the costal inspiration, which lowers the diaphragm, the liver is pumped
Intervention code [1] 290543 0
Treatment: Other
Comparator / control treatment
Subjects in the Control Group followed exactly the same process for measurements, positions, contacts and breathing as the Experimental Group, with the only exception being the pumping. In lieu of any force, the therapist's hands will limited to accompanying the respiratory movements with no compression.
Control group
Placebo

Outcomes
Primary outcome [1] 293517 0
Evaluate the effects of the isolated liver pumping technique, on portal venous flow, using Doppler ultrasound
Timepoint [1] 293517 0
immediately following completion of treatment
Secondary outcome [1] 311233 0
Evaluate the effects of the isolated liver pumping technique, on portal venous diameter, using Doppler ultrasound
Timepoint [1] 311233 0
immediately following completion of treatment

Eligibility
Key inclusion criteria
Inclusion criteria will be subjects of both sexes who seek an osteopathy consultation for any disorder whose pathophysiology has been related with the function of the liver by some author (spinal pains, headaches, sprained ankle ...), aged between 18 and 65 years, must have fasted for at least 8 hours and tolerating the supine position
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Subjects presenting the following could not participate in the study (i) contraindication or intolerance to coastal compression, (ii) psychotic problems, (iii) primary cancer or current metastases, (iv) current gastrointestinal bleeding, (v) liver transplants ( vi) polycystic liver or hepatobiliary infarction (vii) intra-abdominal infection or inflammation in acute phase, (viii) chronic liver disease of any etiology, (ix) decompensated heart failure (x) subjects who are receiving chemotherapy and / or radiotherapy, (xi) pregnant women, (xii) and subjects with a waist circumference greater than 88 cm in women and 102 cm in men, for better ultrasound visualization

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The subjects will be formed through random ballots in sealed envelopes, assigning to the Experimental Group (EG) those subjects who draw a ballot with the number 1, and to the Control Group (CG) those subjects who drew a ballot with the number 2. An outside co-worker safeguard the sequence for those participating in the study.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
This trial use simple randomisation. Participants randomly removed, being removed from the rest chosen on envelopes, sealed envelopes with numbers 1 and 2 written. Be so formed two groups: an intervention group and a control group. Assigning to the Experimental Group (EG) those subjects who draw a ballot with the number 1, and to the Control Group (CG) those subjects who drew a ballot with the number 2
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
18/05/2015
Actual
18/05/2015
Date of last participant enrolment
Anticipated
Actual
19/11/2015
Date of last data collection
Anticipated
Actual
11/10/2017
Sample size
Target
46
Accrual to date
Final
46
Recruitment outside Australia
Country [1] 6450 0
Spain
State/province [1] 6450 0
Madrid

Funding & Sponsors
Funding source category [1] 290186 0
Commercial sector/Industry
Name [1] 290186 0
Hitachi
Country [1] 290186 0
Spain
Primary sponsor type
Individual
Name
Elena Sonsoles Rodriguez Lopez
Address
pza nicaragua, 9, 9 A
Mostoles
28936 Madrid
Country
Spain
Secondary sponsor category [1] 288898 0
Individual
Name [1] 288898 0
Angel Oliva Pascual Vaca
Address [1] 288898 0
pza nicaragua, 9, 9 A
Mostoles
28936 Madrid
Country [1] 288898 0
Spain

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 291896 0
SEFO- scientific european federation osteopaths
Ethics committee address [1] 291896 0
Ethics committee country [1] 291896 0
Spain
Date submitted for ethics approval [1] 291896 0
21/01/2015
Approval date [1] 291896 0
11/02/2015
Ethics approval number [1] 291896 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 52494 0
Dr Elena Sonsoles Rodriguez Lopez
Address 52494 0
Plaza de Nicaragua, 9, 9 A.
28936 Mostoles (Madrid)
Country 52494 0
Spain
Phone 52494 0
+34679336394
Fax 52494 0
Email 52494 0
[email protected]
Contact person for public queries
Name 52495 0
Elena Sonsoles Rodriguez Lopez
Address 52495 0
Plaza de Nicaragua, 9, 9 A.
28936 Mostoles (Madrid)
Country 52495 0
Spain
Phone 52495 0
+34679336394
Fax 52495 0
Email 52495 0
[email protected]
Contact person for scientific queries
Name 52496 0
Elena Sonsoles Rodriguez Lopez
Address 52496 0
Plaza de Nicaragua, 9, 9 A.
28936 Mostoles (Madrid)
Country 52496 0
Spain
Phone 52496 0
+34679336394
Fax 52496 0
Email 52496 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.